Home
Click

Centre for Cancer Biomarkers CCBIO

Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine, University of Bergen. 

The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis. Centre Director is Lars A. Akslen, Department of Clinical Medicine. Read about our research and activities in the CCBIO Annual Report.

Project managers
CCBIO has eight principal investigators, and three associated investigators:

cancer research meeting

Successful p53 meeting in Bergen

The p53 community met at Haukeland Campus for the 3rd international p53 isoform conference, 18th to 21st of June. CCBIO had the great pleasure of hosting The Third International p53 Isoform conference at Basic Biology-building, UIB Haukeland Campus. We welcomed researchers from all corners of the...

Biomarkers meet bioinformatics

Detecting biomarkers through bioinformatics

The Centre for Cancer Biomarkers CCBIO, in collaboration with Helse Vest, arranged on June 18.-19. 2017 a new type of symposium focusing on the methodology required to identify new biomarkers in patient materials.

New doctorate - cancer research

The role of the microenvironment in tumors

Inga Reigstad defended Thursday June 22nd 2017 her dissertation "Investigation of different aspects of the tumor microenvironment as determinants of tumor development and progression".

New doctorate - cancer research

Biomarkers in breast cancer

Sura Aziz defended Tuesday June 27th 2017 her dissertation: “Biological and clinico-pathologic markers in breast cancer, with focus on histologic features, markers of proliferation and angiogenesis” at the University of Bergen.

New doctorate - cancer research

Biomarkers of endometrial cancer

Anna Berg defended June 22nd 2017 her dissertation: «Molecular alterations and diagnostic imaging in premalignant and malignant endometrial lesions for improved diagnosis and treatment» at the University of Bergen.

Shortcuts: Read CCBIO's Annual Reports and the CCBIO Newsletter

CCBIO is established in 2013 by the Research Council of Norway in collaboration with the University of Bergen. Other important sources of financial support are Helse Vest and the Norwegian Cancer Society. CCBIO is part of the Research Council of Norway's Centres of Excellence (CoE) scheme. The scheme organizes the activities of Norway’s foremost scientific circles in centres to achieve ambitious scientific objectives through collaboration and long-term basic funding.